Evidence map›Paper›PMID 35268821›Full record

ArticleMolecules (Basel, Switzerland)2022

Effects of Shrimp Peptide Hydrolysate on Intestinal Microbiota Restoration and Immune Modulation in Cyclophosphamide-Treated Mice.

Asif Iqbal Khan, Ata Ur Rehman, Nabeel Ahmed Farooqui, Nimra Zafar Siddiqui, Qamar Ayub, Muhammad Noman Ramzan, Liang Wang, Yi Xin

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Immunomodulatory Peptides Derived fromFoods (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Anti-Inflammatory Activity of Peptides fromFoods (Basel, Switzerland) · 2024
    Article
  13. Paraprobiotic derived fromFrontiers in immunology · 2024
    Article
  14. The P4' Peptide-CarryingAquaculture nutrition · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Natural Products for Chronic Diseases: A Ray of Hope.Molecules (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Asif Iqbal KhanDepartment of Biotechnology, College of Basic Medical Science, Dalian Medical University, Dalian 116044, China.ORCID 0000-0002-0564-2884
Ata Ur RehmanDepartment of Biotechnology, College of Basic Medical Science, Dalian Medical University, Dalian 116044, China.
Nabeel Ahmed FarooquiDepartment of Biotechnology, College of Basic Medical Science, Dalian Medical University, Dalian 116044, China.
Nimra Zafar SiddiquiDepartment of Biotechnology, College of Basic Medical Science, Dalian Medical University, Dalian 116044, China.
Qamar AyubCollege of Clinical Laboratory Sciences, Dalian Medical University, Dalian 116044, China.
Muhammad Noman RamzanDepartment of Biochemistry and Molecular Biology, College of Basic Medical Science, Dalian Medical University, Dalian 116044, China.ORCID 0000-0003-1917-1611
Liang WangStem Cell Clinical Research Center, National Joint Engineering Laboratory, Regenerative Medicine Center, The First Affiliated Hospital of Dalian Medical University, No. 193, Lianhe Road, Shahekou District, Dalian 116011, China.ORCID 0000-0003-2244-7535
Yi XinDepartment of Biotechnology, College of Basic Medical Science, Dalian Medical University, Dalian 116044, China.ORCID 0000-0002-6988-5121
Dalian Medical University · CN

Funding

National Nature Science Foundation of China 31600614,82072953Top young talents of Liaoning Provincial Government XLYC1907009
6 · The paper itself

Abstract

The gut microbiota is important in regulating host metabolism, maintaining physiology, and protecting immune homeostasis. Gut microbiota dysbiosis affects the development of the gut microenvironment, as well as the onset of various external systemic diseases and metabolic syndromes. Cyclophosphamide (CTX) is a commonly used chemotherapeutic drug that suppresses the host immune system, intestinal mucosa inflammation, and dysbiosis of the intestinal flora. Immunomodulators are necessary to enhance the immune system and prevent homeostasis disbalance and cytotoxicity caused by CTX. In this study, shrimp peptide hydrolysate (SPH) was evaluated for immunomodulation, intestinal integration, and microbiota in CTX-induced immunosuppressed mice. It was observed that SPH would significantly restore goblet cells and intestinal mucosa integrity, modulate the immune system, and increase relative expression of mRNA and tight-junction associated proteins (Occludin, Zo-1, Claudin-1, and Mucin-2). It also improved gut flora and restored the intestinal microbiota ecological balance by removing harmful microbes of various taxonomic groups. This would also increase the immune organs index, serum levels of cytokines (IFN-ϒ, IL1β, TNF-α, IL-6), and immunoglobin levels (IgA, IgM). The Firmicutes/Bacteroidetes proportion was decreased in CTX-induced mice. Finally, SPH would be recommended as a functional food source with a modulatory effect not only on intestinal microbiota, but also as a potential health-promoting immune function regulator.

Indexed as

Gastrointestinal MicrobiomeAnimalsCyclophosphamideDysbiosisImmunityIntestinal MucosaMicePeptidesCyclophosphamidePeptidescyclophosphamidegut healthimmunosuppression gut microbiotapeptidesshrimp (Penaeus Chinensis)

Identifiers

PMID35268821
PMCPMC8911659
OpenAlexW4220651983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.